Top Healthcare Stocks
Healthcare stocks are holding on to finish higher today with the
NYSE Healthcare Sector Index advancing 0.1% and shares of
healthcare companies in the S&P 500 adding 0.3% as a group.
In company news, Shares of Progenics Pharmaceuticals Inc. (
) is finishing nearly 4% today to $4.78 a share after the
biopharmaceutical company said it is resuming a Phase IIb study of
its Azedra-targeted radiotherapy in patients suffering from rare
endocrine tumors called pheochromocytomas.
Azedra originally was developed by the company's Molecular
Insight Pharmaceuticals subsidiary, which began the study under a
2009 Special Protocol Assessment from the Food and Drug
Administration. In late 2010, MIP suspended the trial with
enrollment two-thirds complete in order to seek additional
In other sector news,
(+) PBMD, Shares rally as much as 76% following a presentation
by the Australian biotech's CEO on its prospective cancer vaccine
as part of broader presentation this morning on immunocellular cell
therapy at an industry conference in London.
(-) CLDX, Said interim data from ongoing Phase II testing of its
rindopepimut drug candidate in patients with recurrent glioblastoma
showed promising signs of clinical activity in advanced patient
Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.